[1]王玉东.静脉溶栓联合动脉取栓治疗急性缺血性脑卒中的疗效及安全性[J].新乡医学院学报,2019,36(8):764-767.[doi:10.7683/xxyxyxb.2019.08.015]
　WANG Yu-dong.Effect and safety of arteriovenous combined vascular recanalization in the treatment of acute cerebral apoplexy[J].Journal of Xinxiang Medical University,2019,36(8):764-767.[doi:10.7683/xxyxyxb.2019.08.015]
点击复制

静脉溶栓联合动脉取栓治疗急性缺血性脑卒中的疗效及安全性
分享到：

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
36
期数:
2019年8
页码:
764-767
栏目:
临床研究
出版日期:
2019-08-05

文章信息/Info

Title:
Effect and safety of arteriovenous combined vascular recanalization in the treatment of acute cerebral apoplexy
作者:
王玉东
（驻马店市中心医院急诊科，河南　驻马店　463000）
Author(s):
WANG Yu-dong
(Department of Emergency,Zhumadian Central Hospital,Zhumadian 463000,Henan Province,China)
关键词:
急性缺血性脑卒中; 静脉溶栓; 动脉取栓; 血管再通
Keywords:
acute ischemic stroke; intravenous thrombolysis; arterial thrombolysis; vascular recanalization
分类号:
R743.3
DOI:
10.7683/xxyxyxb.2019.08.015
文献标志码:
A
摘要:
目的　探讨静脉溶栓联合动脉取栓治疗急性缺血性脑卒中的疗效及安全性。方法　选择2015年1月至2018年3月驻马店市中心医院收治的80例急性缺血性脑卒中患者作为研究对象，采用随机数字表法将患者分为对照组和观察组，每组40例。2组患者均给予重组组织型纤溶酶原激活剂（0.9 mg·kg-1，总剂量控制在90 mg以内）进行静脉溶栓治疗；在此基础上，观察组患者给予动脉血管内支架取栓治疗。比较2组患者治疗后血管再通率、临床疗效及预后；分别于治疗前后采用美国国立卫生研究院卒中量表（NIHSS）评估2组患者的神经功能损伤程度，采用Barthel指数评估2组患者的日常生活能力，采用生活质量综合评定量表评估2组患者的生活质量。采用酶联免疫吸附试验检测2组患者血清炎症因子水平。结果　观察组和对照组患者血管再通率分别为77.50%（31/40）、35.00%（14/40），总有效率分别为95.00%（38/40）、75.00%（30/40），观察组患者血管再通率和总有效率均显著高于对照组（χ2=14.679、6.275，P<0.05）。治疗前2组患者NIHSS评分及Barthel指数比较差异无统计学意义（P>0.05）；2组患者治疗后NIHSS评分低于治疗前，Barthel指数高于治疗前（P<0.05）；治疗后，观察组患者NIHSS评分低于对照组，Barthel指数高于对照组（P<0.05）。治疗前2组患者的血清C反应蛋白（CRP）、白细胞介素-6（IL-6）及降钙素原（PCT）水平比较差异无统计学意义（P>0.05）；治疗后2组患者血清CRP、IL-6及PCT水平低于治疗前（P<0.05）；治疗后，观察组患者血清CRP、IL-6及PCT水平均低于对照组（P<0.05）。观察组和对照组患者症状性颅内出血率分别为7.50%（3/40）、5.00%（2/40），2组患者症状性颅内出血率比较差异无统计学意义（χ2=0.213，P>0.05）。观察组患者中预后良好病例数多于对照组（χ2=4.053，P<0.05）；轻度残疾率、重度残疾率、植物生存率、病死率与对照组比较差异无统计学意义（χ2=0.220、2.222、2.051、1.013，P>0.05）。治疗前2组患者躯体功能、心理健康、社会关系、生活环境得分比较差异均无统计学意义（P>0.05）；2组患者治疗后躯体功能、心理健康、社会关系、生活环境得分均高于治疗前（P<0.05）；治疗后，观察组患者躯体功能、心理健康、社会关系、生活环境得分均高于对照组（P<0.05）。结论　静脉溶栓联合动脉取栓治疗急性缺血性脑卒中可有效促使血管再通，改善患者神经功能、日常生活能力和生活质量。
Abstract:
Objective　To investigate the effect and safety of intravenous thrombolysis combined with arterial thrombectomy in the treatment of acute ischemic stroke.Methods　Eighty patients with acute ischemic stroke admitted to Zhumadian Central Hospital from January 2015 to March 2018 were selected as the study subjects.The patients were divided into control group and observation group by random number table method,with 40 cases in each group.All patients were given intravenous thrombolysis with recombinant tissue plasminogen activator (0.9 mg·kg-1,the total dose controlled within 90 mg).Based on this,the patients in the observation group were given intravascular stent thrombolysis.Vascular recanalization rate,clinical efficacy and prognosis were compared between the two groups after treatment.Neurological impairment was assessed by National Institutes of Health Stroke Scale (NIHSS) before and after treatment;the daily living ability was assessed by Barthel index;and the quality of life was assessed by comprehensive assessment scale.The levels of serum inflammatory factors were detected by enzyme linked immunosorbent assay in the two groups.Results　The vessel recanulation rate of patients in the observation group and control group was 77.50% (31/40),35.00% (14/40),and the total effective rate was 95.00% (38/40) and 75.00% (30/40),respectively.The vessel recanulation rate and total effective rate of patients in the observation group were significantly higher than those in the control group (χ2=14.679,6.275;P<0.05).There was no significant difference in the NIHSS score and Barthel index between the two groups before treatment (P>0.05).After treatment,the NIHSS score was lower than that before treatment,and the Barthel index was higher than that before treatment (P<0.05).After treatment,the NIHSS score of patients in the observation group was lower than that in the control group,and the Barthel index was higher than that in the control group (P<0.05).There was no significant difference in the serum levels of C-reactive protein(CRP),interleukin-6 (IL-6) and procalcitonin (PCT) between the two groups before treatment (P>0.05).The serum levels of CRP,IL-6 and PCT of patients after treatment were lower than those before treatment in the two groups(P<0.05).After treatment,the serum levels of CRP,IL -6 and PCT of patients in the observation group were lower than those in the control group (P<0.05).The rates of symptomatic intracranial hemorrhage of patients in the observation group and control group were 7.50% (3/40) and 5.00% (2/40),respectively;there was no statistic difference in the rates of symptomatic intracranial hemorrhage between the two groups (χ2=0.213,P>0.05).The number of patients with better prognosis in the observation group was higher than that in the control group (χ2=4.053,P<0.05);there were no statistic differences in the rates of mild disability,severe disability,plant survival and mortality between the two groups (χ2=0.220,2.222,2.051,1.013;P>0.05).There was no statistic difference in the scores of physical function,mental health,social relations and living environment between the two groups before treatment (P>0.05).The scores of physical function,mental health,social relationship and living environment of patients after treatment were higher than those before treatment in the two groups (P<0.05).After treatment,the scores of physical function,mental health,social relationship and living environment of patients in the observation group were higher than those in the control group (P<0.05).Conclusion　Intravenous thrombolysis combined with arterial thrombectomy in the treatment of acute ischemic stroke can effectively promote blood vessel recanalization,improve neurological function,daily living ability and quality of life of patients.

参考文献/References:

［1］　李艳琴.动静脉联合溶栓对急性脑梗死患者预后的影响［J］.中国实用神经疾病杂志,2016,19(20):29-30.
［2］　方洁,唐学梅,王硕,等.动静脉联合血管再通治疗急性脑卒中的疗效和安全性分析［J］.中国临床神经科学,2015,23(5):481-487.
［3］　NAM J,JING H,O′REILLY D,et al.Intra-arterial thrombolysis vs.standard treatment or intravenous thrombolysis in adults with acute ischemic stroke:a systematic review and meta-analysis［J］.Int J Stroke,2015,10(1):13-22.
［4］　王朝斌,侯立刚.动脉溶栓与动静脉溶栓对急性期缺血性脑卒中病人血管再通率、症状性脑出血发生率及病死率的影响［J］.中西医结合心脑血管病杂志,2017,15(19):2480-2482.
［5］　徐江涛,黄宇靖,张为良,等.急性缺血性卒中血管再通治疗的最新进展与展望［J］.神经疾病与精神卫生,2017,17(5):305-307.
［6］　周华勇,龙继发,季一飞,等.动静脉联合溶栓及机械取栓治疗急性脑梗死的效果［J］.中国临床研究,2018,31(2):211-214.
［7］　汤海潮,许晓丹,姚懿函,等.动静脉联合应用重组组织型纤溶酶原激活剂治疗超时间窗急性脑梗死患者近期预后影响因素分析［J］.临床军医杂志,2017,45(8):784-786.
［8］　成峰,吴宗艺.静脉溶栓联合血管内治疗对急性后循环脑梗死临床疗效分析［J］.深圳中西医结合杂志,2016,26(3):95-97.
［9］　许皓莉.动静脉联合溶栓对急性脑梗死患者预后的影响分析［J］.中国实用神经疾病杂志,2017,20(2):71-73.
［10］　方嘉阳,陈贞君,李华,等.动静脉溶栓治疗急性脑梗死对比研究［J］.中国实用神经疾病杂志,2015,18(12):26-27.
［11］　PACIARONI M,INZITARI D,AGNELLI G,et al.Intravenous thrombolysis or endovascular therapy for acute ischemic stroke associated with cervical internal carotid artery occlusion:the ICARO-3 study［J］.J Neurol,2015,262(2):459-468.
［12］　廖晓凌,王伊龙,潘岳松,等.急性大脑中动脉闭塞性脑梗死静脉溶栓后血管再通与预后［J］.中国卒中杂志,2016,11(10):824-828.
［13］　倪贵华,梁晨,赵卫东,等.三种不同血管再通方法治疗椎基底动脉闭塞性脑梗死的疗效对比［J］.中华医学杂志,2017,97(13):1001-1005.
［14］　胡昔奇,夏鹰.急性缺血性脑卒中机械性取栓研究进展［J］.中国老年学杂志,2015,35(17):5023-5025.
［15］　傅懋林,戴为正,张永刚,等.Solitaire支架动脉取栓术联合多模式血管再通术治疗急性脑梗死疗效观察［J］.天津医药,2017,45(10):1053-1057.

相似文献/References:

[1]武素军,姜淑英,侯秀珍.尿激酶静脉溶栓治疗急性脑梗塞的护理[J].新乡医学院学报,2000,17(03):227.
[2]魏　亮,张小峰,张军峰.阿替普酶治疗急性脑梗死疗效观察[J].新乡医学院学报,2019,36(6):533.[doi:10.7683/xxyxyxb.2019.06.008]
　WEI Liang,ZHANG Xiao-feng,ZHANG Jun-feng.Effect of alteplase on acute cerebral infarction[J].Journal of Xinxiang Medical University,2019,36(8):533.[doi:10.7683/xxyxyxb.2019.06.008]
[3]陶培洪,孟　涛,杨　柳,等.急性缺血性脑卒中患者血清Sestrin2、神经胶质原纤维酸性蛋白和泛素羧基末端水解酶-１水平变化及预后影响因素分析[J].新乡医学院学报,2021,38(12):1175.[doi:10.7683/xxyxyxb.2021.12.014]
　TAO Peihong,MENG Tao,YANG Liu,et al.Changes of serum Sestrin2,glial fibrillary acidic protein,ubiquitin carboxy-terminal hydrolase-1 levels in patients with acute ischemic stroke and analysis of prognostic factors[J].Journal of Xinxiang Medical University,2021,38(8):1175.[doi:10.7683/xxyxyxb.2021.12.014]
[4]孟　涛,李成刚,杨　柳,等.血清脑源性神经生长因子、神经元PAS结构域蛋白4和神经元特异性烯醇化酶水平与急性缺血性脑卒中患者认知障碍的关系[J].新乡医学院学报,2022,39(8):777.[doi:10.7683/xxyxyxb.2022.08.015]
　MENG Tao,LI Chenggang,YANG Liu,et al.Relationship between the levels of brain-derived nerve growth factor,neuronal Per-Arnt-Sim domain protein 4,neuron-specific enolase and cognitive disorder in serum of patients with acute ischemic stroke[J].Journal of Xinxiang Medical University,2022,39(8):777.[doi:10.7683/xxyxyxb.2022.08.015]
[5]录海斌,郭耀强,王晓洁.中性粒细胞/淋巴细胞比值对不伴感染症状的急性缺血性卒中患者静脉溶栓预后的预测价值[J].新乡医学院学报,2023,40(2):136.[doi:10.7683/xxyxyxb.2023.02.007]
　LU Haibin,GUO Yaoqiang,WANG Xiaojie.Predictive value of neutrophil-to-lymphocyte ratio for prognosis of intravenous thrombolysis in treatment of acute ischemic stroke in patients without symptoms of infection[J].Journal of Xinxiang Medical University,2023,40(8):136.[doi:10.7683/xxyxyxb.2023.02.007]
[6]李令培,马新安,张超,等.急性脑梗死静脉溶栓后继发出血转化危险因素分析及预测模型构建[J].新乡医学院学报,2023,40(4):366.[doi:10.7683/xxyxyxb.2023.04.013]
　LI Lingpei,MA Xinan,ZHANG Chao,et al.Risk factors analysis and establishment of predictive model of secondary hemorrhagic transformation after intravenous thrombolysis in acute cerebral infarction[J].Journal of Xinxiang Medical University,2023,40(8):366.[doi:10.7683/xxyxyxb.2023.04.013]
[7]王继存,王剑新.神经介入辅助阿替普酶溶栓治疗急性缺血性脑卒中疗效观察[J].新乡医学院学报,2024,(1):032.[doi:10.7683/xxyxyxb.2024.01.006]
　WANG Jicun,WANG Jianxin.Therapeutic effect of neurointervention assisted alteplase thrombolysis in the treatment of acute ischemic stroke[J].Journal of Xinxiang Medical University,2024,(8):032.[doi:10.7683/xxyxyxb.2024.01.006]

更新日期/Last Update: 2019-08-05